Cannabis Science Profile

0.0467
USD 0.0006  1.30%
27%
67%

Sale by Robert Kane of 503345 shares of Cannabis Science

Cannabis Science insider trading alert for sale of common stock by Robert Kane, CFO, on September 16, 2018. This event was filed by Cannabis Science Inc with SEC on 2016-05-23. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Cannabis Science Summary

Cannabis Science (CBIS) is traded on OTC Market in USA. It is located in 19800 MacArthur Boulevard and employs 1 people. The company currently falls under 'Small-Cap' category with current market capitalization of 126.38 M. Cannabis Science conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. This company has 2.74 B outstanding shares. CANNABIS SCIENCE currently holds about 29.29 K in cash with (1.58 M) of positive cash flow from operations.
Check Cannabis Science Probability Of Bankruptcy

Ownership Allocation (%)

Cannabis Science Target Price Odds Analysis

Odds Below 0.0467HorizonTargetOdds Above 0.0467
20.57%30 days 0.0467 79.30%
Based on normal probability distribution, the odds of Cannabis Science to move above current price in 30 days from now is about 79.3% (This Cannabis Science probability density function shows the probability of Cannabis Science Stock to fall within a particular range of prices over 30 days) .

Cannabis Science Top Holders

Cannabis Science Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Donaldson Capital Management LlcCommon Shares99.8 K6 K
North Star Asset Management IncCommon Shares40 K2 K
View Cannabis Science Diagnostics

Cannabis Science Risk Profiles

Cannabis Science Key Fundamentals

Cannabis Science Against Markets

Cannabis Science Current Ratings

Cannabis Science 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
48 
Equity ratings for Cannabis Science are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc. Cannabis Science operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. more
NameCannabis Science
ChairmanRaymond DabneyView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address19800 MacArthur Boulevard
ExchangeOTC Market
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.cannabisscience.com
Phone888 263 0832
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2018
Most Recent QuarterSeptember 30, 2017
Last Fiscal Year EndDecember 31, 2016
Check also Trending Equities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com